News

By renewing our driver’s license at the DMV, most of us are aware of the process of registering to become an organ donor should the worst come to pass. But there is another group of organ donors — living donors — who are helping relatives, friends and even strangers by donating a kidney or part of their liver. Living donors who choose to give a kidney — the most commonly donated organ — can live a full life with the remaining kidney.

Think of the word “infertility,” and you might picture a couple without children struggling to get pregnant or stay pregnant. But there is another set of people — those who have successfully conceived and given birth to one or more children — who struggle with infertility, too. Called secondary infertility, the condition often carries an extra burden: Those affected by it might feel guilty over wanting another child; those close to them may be unsympathetic because they are already a parent; or frustrated because getting pregnant the first (or second) time was relatively easy.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.